{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:26:47Z","timestamp":1785407207135,"version":"3.56.0"},"reference-count":135,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.det.2024.02.005","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T14:32:12Z","timestamp":1711117932000},"page":"439-469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Role of Genetics on Psoriasis Susceptibility, Comorbidities, and Treatment Response"],"prefix":"10.1016","volume":"42","author":[{"given":"Audrey","family":"Bui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faye","family":"Orcales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Kranyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Young","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Haran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payton","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandler","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.det.2024.02.005_bib1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.02.005_bib2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jaad.2013.11.013","article-title":"Psoriasis prevalence among adults in the United States","volume":"70","author":"Rachakonda","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.02.005_bib3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/bjd.12375","article-title":"Heritability of psoriasis in a large twin sample","volume":"169","author":"Lonnberg","year":"2013","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.02.005_bib4","first-page":"23","article-title":"Genetic background of psoriasis","volume":"4","author":"Alshobaili","year":"2010","journal-title":"Int J Health Sci"},{"issue":"12","key":"10.1016\/j.det.2024.02.005_bib5","first-page":"18","article-title":"The Genetic Basis of Psoriasis","author":"Capon","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.det.2024.02.005_bib6","doi-asserted-by":"crossref","first-page":"J314","DOI":"10.1016\/j.jaut.2009.12.001","article-title":"Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis","volume":"34","author":"Chandran","year":"2010","journal-title":"J\u00a0Autoimmun"},{"issue":"1","key":"10.1016\/j.det.2024.02.005_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2340\/00015555-2171","article-title":"Genetic Factors Explain Variation in the Age at Onset of Psoriasis: A Population-based Twin Study","volume":"96","author":"Lonnberg","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.det.2024.02.005_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/511051","article-title":"A\u00a0large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes","volume":"80","author":"Cargill","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.det.2024.02.005_bib9","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ajhg.2015.10.019","article-title":"Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture","volume":"97","author":"Stuart","year":"2015","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.det.2024.02.005_bib10","doi-asserted-by":"crossref","first-page":"15382","DOI":"10.1038\/ncomms15382","article-title":"Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants","volume":"8","author":"Tsoi","year":"2017","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.det.2024.02.005_bib11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0190-9622(85)70188-0","article-title":"Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris","volume":"13","author":"Henseler","year":"1985","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2024.02.005_bib12","doi-asserted-by":"crossref","first-page":"e19454","DOI":"10.1371\/journal.pone.0019454","article-title":"A\u00a0genetic risk score combining ten psoriasis risk loci improves disease prediction","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.det.2024.02.005_bib13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2020.05.008","article-title":"The current landscape of psoriasis genetics in 2020","volume":"99","author":"Ogawa","year":"2020","journal-title":"J\u00a0Dermatol Sci"},{"issue":"10","key":"10.1016\/j.det.2024.02.005_bib14","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1371\/journal.pgen.0030190","article-title":"Copy number variants and common disorders: filling the gaps and exploring complexity in genome-wide association studies","volume":"3","author":"Estivill","year":"2007","journal-title":"PLoS Genet"},{"issue":"1","key":"10.1016\/j.det.2024.02.005_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.sder.2010.01.002","article-title":"Comorbidities in psoriasis patients","volume":"29","author":"Kim","year":"2010","journal-title":"Semin Cutan Med Surg"},{"issue":"10","key":"10.1016\/j.det.2024.02.005_bib16","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.jid.2021.02.743","article-title":"New Frontiers in Psoriatic Disease Research, Part II: Comorbidities and Targeted Therapies","volume":"141","author":"Yan","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.02.005_bib17","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jid.2022.11.014","article-title":"Mendelian Randomization Studies in Psoriasis and Psoriatic Arthritis: A Systematic Review","volume":"143","author":"Jin","year":"2023","journal-title":"J\u00a0Invest Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.02.005_bib18","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/jid.2012.366","article-title":"Association of cardiovascular and metabolic disease genes with psoriasis","volume":"133","author":"Lu","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"issue":"16","key":"10.1016\/j.det.2024.02.005_bib19","first-page":"22","article-title":"Analysis of the Potential Genetic Links between Psoriasis and Cardiovascular Risk Factors","volume":"23","author":"Purzycka-Bohdan","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.det.2024.02.005_bib20","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1172\/JCI28508","article-title":"The IL-23\/IL-17 axis in inflammation","volume":"116","author":"Iwakura","year":"2006","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.det.2024.02.005_bib21","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8- entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.det.2024.02.005_bib22","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jamadermatol.2013.5264","article-title":"Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011","volume":"149","author":"Armstrong","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"13","key":"10.1016\/j.det.2024.02.005_bib23","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/hmg\/ddn091","article-title":"Identification of ZNF313\/RNF114 as a novel psoriasis susceptibility gene","volume":"17","author":"Capon","year":"2008","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10.1016\/j.det.2024.02.005_bib24","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ng.688","article-title":"Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis","volume":"42","author":"Huffmeier","year":"2010","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.det.2024.02.005_bib25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.311","article-title":"Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways","volume":"41","author":"Nair","year":"2009","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.det.2024.02.005_bib26","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ng.689","article-title":"Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2","volume":"42","author":"Ellinghaus","year":"2010","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.det.2024.02.005_bib27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.molimm.2014.11.015","article-title":"Association analysis of GWAS and candidate gene loci in a Pakistani population with psoriasis","volume":"64","author":"Munir","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.det.2024.02.005_bib28","first-page":"101879","article-title":"Polymorphisms Associated with Age at Onset in Patients with Moderate-to-Severe Plaque Psoriasis","volume":"2015","author":"Prieto-Perez","year":"2015","journal-title":"J\u00a0Immunol Res"},{"issue":"5","key":"10.1016\/j.det.2024.02.005_bib29","doi-asserted-by":"crossref","first-page":"e0217352","DOI":"10.1371\/journal.pone.0217352","article-title":"Low TNFAIP3 expression in psoriatic skin promotes disease susceptibility and severity","volume":"14","author":"Sahlol","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.det.2024.02.005_bib30","doi-asserted-by":"crossref","first-page":"e1000041","DOI":"10.1371\/journal.pgen.1000041","article-title":"A\u00a0genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci","volume":"4","author":"Liu","year":"2008","journal-title":"PLoS Genet"},{"issue":"3","key":"10.1016\/j.det.2024.02.005_bib31","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jid.2017.10.001","article-title":"Variants at HLA-A, HLA-C, and HLA-DQB1 Confer Risk of Psoriasis Vulgaris in Japanese","volume":"138","author":"Hirata","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.02.005_bib32","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/exd.13926","article-title":"Genome-wide association study of psoriasis in an Egyptian population","volume":"28","author":"Bejaoui","year":"2019","journal-title":"Exp Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.02.005_bib33","article-title":"Transethnic analysis of psoriasis susceptibility in South Asians and Europeans enhances fine-mapping in the MHC and genomewide","volume":"3","author":"Stuart","year":"2022","journal-title":"HGG Adv"},{"issue":"4","key":"10.1016\/j.det.2024.02.005_bib34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5021\/ad.22.196","article-title":"A\u00a0Pilot Genome-Wide Association Study Identifies Novel Markers of Metabolic Syndrome in Patients with Psoriasis","volume":"35","author":"Oh","year":"2023","journal-title":"Ann Dermatol"},{"issue":"12","key":"10.1016\/j.det.2024.02.005_bib35","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1038\/jid.2010.214","article-title":"Carriers of rare missense variants in IFIH1 are protected from psoriasis","volume":"130","author":"Li","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"issue":"21","key":"10.1016\/j.det.2024.02.005_bib36","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1093\/hmg\/ddx328","article-title":"Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling","volume":"26","author":"Dand","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.det.2024.02.005_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1471-2350-12-167","article-title":"Association analysis identifies ZNF750 regulatory variants in psoriasis","volume":"12","author":"Birnbaum","year":"2011","journal-title":"BMC Med Genet"},{"issue":"5","key":"10.1016\/j.det.2024.02.005_bib38","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajhg.2012.03.012","article-title":"PSORS2 is due to mutations in CARD14","volume":"90","author":"Jordan","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"16","key":"10.1016\/j.det.2024.02.005_bib39","first-page":"23","article-title":"Association of CARD14 Single-Nucleotide Polymorphisms with Psoriasis","author":"Suleman","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.det.2024.02.005_bib40","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajhg.2011.07.022","article-title":"Mutations in IL36RN\/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis","volume":"89","author":"Onoufriadis","year":"2011","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.det.2024.02.005_bib41","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/jid.2012.490","article-title":"Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypes","volume":"133","author":"Setta-Kaffetzi","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"issue":"8","key":"10.1016\/j.det.2024.02.005_bib42","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jid.2023.01.023","article-title":"Identification of the BTN3A3 Gene as a Molecule Implicated in Generalized Pustular Psoriasis in a Chinese Population","volume":"143","author":"Zhang","year":"2023","journal-title":"J\u00a0Invest Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.02.005_bib43","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ajhg.2014.04.005","article-title":"AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 trafficking","volume":"94","author":"Setta-Kaffetzi","year":"2014","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.det.2024.02.005_bib44","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ajhg.2020.07.001","article-title":"Myeloperoxidase Modulates Inflammation in Generalized Pustular Psoriasis and Additional Rare Pustular Skin Diseases","volume":"107","author":"Haskamp","year":"2020","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.det.2024.02.005_bib45","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/1346-8138.16700","article-title":"A\u00a0homozygous loss-of-function variant in the MPO gene is associated with generalized pustular psoriasis","volume":"50","author":"Onitsuka","year":"2023","journal-title":"J\u00a0Dermatol"},{"issue":"7","key":"10.1016\/j.det.2024.02.005_bib46","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.jid.2019.11.024","article-title":"Rare Loss-of-Function Mutation in SERPINA3 in Generalized Pustular Psoriasis","volume":"140","author":"Frey","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"issue":"10","key":"10.1016\/j.det.2024.02.005_bib47","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/1346-8138.16081","article-title":"SERPINA1, generalized pustular psoriasis, and adult-onset immunodeficiency","volume":"48","author":"Kantaputra","year":"2021","journal-title":"J\u00a0Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.02.005_bib48","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s10038-023-01139-z","article-title":"Newly revealed variants of SERPINA3 in generalized pustular psoriasis attenuate inhibition of ACT on cathepsin G","volume":"68","author":"Liu","year":"2023","journal-title":"J\u00a0Hum Genet"},{"issue":"1","key":"10.1016\/j.det.2024.02.005_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ng.2007.48","article-title":"Psoriasis is associated with increased beta-defensin genomic copy number","volume":"40","author":"Hollox","year":"2008","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.det.2024.02.005_bib50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/ng.313","article-title":"Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis","volume":"41","author":"de Cid","year":"2009","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.det.2024.02.005_bib51","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/jid.2011.86","article-title":"Deletion of the late cornified envelope genes LCE3C and LCE3B is associated with psoriasis in a Chinese population","volume":"131","author":"Li","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.02.005_bib52","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/bjd.14081","article-title":"Inhibitory KIR3DL1 alleles are associated with psoriasis","volume":"174","author":"Ahn","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2024.02.005_bib53","doi-asserted-by":"crossref","first-page":"684326","DOI":"10.3389\/fimmu.2021.684326","article-title":"Large-Scale Imputation of KIR Copy Number and HLA Alleles in North American and European Psoriasis Case-Control Cohorts Reveals Association of Inhibitory KIR2DL2 With Psoriasis","volume":"12","author":"Ahn","year":"2021","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.det.2024.02.005_bib54","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/exd.12233","article-title":"Deletion of the activating NKG2C receptor and a functional polymorphism in its ligand HLA-E in psoriasis susceptibility","volume":"22","author":"Zeng","year":"2013","journal-title":"Exp Dermatol"},{"issue":"11","key":"10.1016\/j.det.2024.02.005_bib55","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.jid.2019.03.1157","article-title":"Genetic Study on Small Insertions and Deletions in Psoriasis Reveals a Role in Complex Human Diseases","volume":"139","author":"Zhen","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.02.005_bib56","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/bjd.20752","article-title":"Three novel structural variations at the major histocompatibility complex and IL12B predispose to psoriasis","volume":"186","author":"Zhen","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2024.02.005_bib57","doi-asserted-by":"crossref","first-page":"e934927","DOI":"10.12659\/MSM.934927","article-title":"Copy Number Variation Analysis of IL22 and LCE3C in Different Subtypes of Psoriasis in a Chinese Han Population","volume":"27","author":"Zhu","year":"2021","journal-title":"Med Sci Monit"},{"issue":"6","key":"10.1016\/j.det.2024.02.005_bib58","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jid.2021.08.446","article-title":"Differences in Clinical Features and Comorbid Burden between HLA-C \u221706:02 Carrier Groups in\u00a0>9,000 People with Psoriasis","volume":"142","author":"Douroudis","year":"2022","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2024.02.005_bib59","doi-asserted-by":"crossref","first-page":"adv5209","DOI":"10.2340\/actadv.v103.5209","article-title":"Body Composition, Cardiometabolic Risk Factors and Comorbidities in Psoriasis and the Effect of HLA-C\u221706:02 Status: The HUNT Study, Norway","volume":"103","author":"Solvin","year":"2023","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2024.02.005_bib60","doi-asserted-by":"crossref","first-page":"1451193","DOI":"10.1155\/2022\/1451193","article-title":"Potential Differences in the Cardiometabolic Risk Profile of Patients with Psoriatic Disease according to Their HLA-C \u221706 Status","volume":"2022","author":"Queiro","year":"2022","journal-title":"BioMed Res Int"},{"issue":"4","key":"10.1016\/j.det.2024.02.005_bib61","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5021\/ad.21.100","article-title":"Correlation of HLA-Cw6 Positivity with Clinical Characteristics and Treatment Efficacy in Korean Patients with Psoriasis","volume":"34","author":"Kim","year":"2022","journal-title":"Ann Dermato"},{"issue":"6","key":"10.1016\/j.det.2024.02.005_bib62","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jid.2020.11.025","article-title":"Causal Relationship and Shared Genetic Loci between Psoriasis and Type 2 Diabetes through Trans-Disease Meta-Analysis","volume":"141","author":"Patrick","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.02.005_bib63","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4103\/ijd.ijd_45_21","article-title":"Early-Onset Versus Late-Onset Psoriasis: A Comparative Study of Clinical Variables, Comorbidities, and Association with HLA CW6 in a Tertiary Care Center","volume":"66","author":"Fatema","year":"2021","journal-title":"Indian J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.02.005_bib64","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s40291-019-00423-z","article-title":"HLA Correlations with Clinical Phenotypes and Risk of Metabolic Comorbidities in Singapore Chinese Psoriasis Patients","volume":"23","author":"Shen","year":"2019","journal-title":"Mol Diagn Ther"},{"issue":"13","key":"10.1016\/j.det.2024.02.005_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137396","article-title":"The Analysis of a Genome-Wide Association Study (GWAS) of Overweight and Obesity in Psoriasis","volume":"23","author":"Kisielnicka","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.det.2024.02.005_bib66","first-page":"69","article-title":"Gene polymorphisms of TNF-238G\/A, TNF-308G\/A, IL10-1082G\/A, TNFAIP3, and MC4R and comorbidity occurrence in a Romanian population with psoriasis","volume":"11","author":"Voiculescu","year":"2018","journal-title":"J\u00a0Med Life"},{"issue":"1","key":"10.1016\/j.det.2024.02.005_bib67","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/10715762.2019.1698738","article-title":"Association between genetic polymorphisms of glutathione S-transferase M1\/T1 and psoriasis in a population from the area of the Strait of Messina(Southern Italy)","volume":"54","author":"Guarneri","year":"2020","journal-title":"Free Radic Res"},{"issue":"1","key":"10.1016\/j.det.2024.02.005_bib68","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1038\/s41467-022-34323-4","article-title":"Shared genetic risk factors and causal association between psoriasis and coronary artery disease","volume":"13","author":"Patrick","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.det.2024.02.005_bib69","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s12916-022-02617-5","article-title":"Psoriasis and cardiovascular disease risk in European and East Asian populations: evidence from meta-analysis and Mendelian randomization analysis","volume":"20","author":"Zhang","year":"2022","journal-title":"BMC Med"},{"issue":"5","key":"10.1016\/j.det.2024.02.005_bib70","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1080\/08820139.2021.1923734","article-title":"Psoriasis Susceptibility 1 Candidate 1 (PSORS1C1) Polymorphism is Associated with Autoimmune Thyroid Disease in a Chinese Han Population","volume":"51","author":"Jiang","year":"2022","journal-title":"Immunol Invest"},{"issue":"8","key":"10.1016\/j.det.2024.02.005_bib71","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1097\/RHU.0000000000001268","article-title":"A\u00a0Family With A20 Haploinsufficiency Presenting With Novel Clinical Manifestations and Challenges for Treatment","volume":"27","author":"Hautala","year":"2021","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.det.2024.02.005_bib72","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ana.26672","article-title":"Shared Genetic Risk Factors for Multiple Sclerosis\/Psoriasis Suggest Involvement of Interleukin-17 and Janus Kinase-Signal Transducers and Activators of Transcription Signaling","volume":"94","author":"Patrick","year":"2023","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.det.2024.02.005_bib73","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12916-021-01903-y","article-title":"Genome-wide genetic links between amyotrophic lateral sclerosis and autoimmune diseases","volume":"19","author":"Li","year":"2021","journal-title":"BMC Med"},{"issue":"2","key":"10.1016\/j.det.2024.02.005_bib74","doi-asserted-by":"crossref","first-page":"247","DOI":"10.25259\/IJDVL_988_19","volume":"89","author":"Chhabra","year":"2023","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"10","key":"10.1016\/j.det.2024.02.005_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/genes12101601","article-title":"Impact of ABCG2 Gene Polymorphism on the Predisposition to Psoriasis","volume":"12","author":"Huang","year":"2021","journal-title":"Genes"},{"issue":"8","key":"10.1016\/j.det.2024.02.005_bib76","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/sj.jid.5700808","article-title":"Polymorphisms in folate, pyrimidine, and purine metabolism are associated with efficacy and toxicity of methotrexate in psoriasis","volume":"127","author":"Campalani","year":"2007","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2024.02.005_bib77","doi-asserted-by":"crossref","first-page":"869912","DOI":"10.3389\/fmed.2022.869912","article-title":"MTHFR Gene Polymorphism Association With Psoriatic Arthritis Risk and the Efficacy and Hepatotoxicity of Methotrexate in Psoriasis","volume":"9","author":"Zhu","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.det.2024.02.005_bib78","doi-asserted-by":"crossref","first-page":"111456","DOI":"10.1016\/j.biopha.2021.111456","article-title":"Polymorphisms in GNMT and DNMT3b are associated with methotrexate treatment outcome in plaque psoriasis","volume":"138","author":"Grzelj","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.det.2024.02.005_bib79","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2133.2008.08898.x","article-title":"Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms","volume":"160","author":"Warren","year":"2009","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.02.005_bib80","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/ced.13100","article-title":"HLA-Cw6-positive patients with psoriasis show improved response to methotrexate treatment","volume":"42","author":"West","year":"2017","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.det.2024.02.005_bib81","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/bjd.17704","article-title":"TT genotype of rs10036748 in TNIP1 shows better response to methotrexate in a Chinese population: a prospective cohort study","volume":"181","author":"Yan","year":"2019","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.det.2024.02.005_bib82","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00228-017-2255-x","article-title":"Pharmacogenetic markers to predict the clinical response to methotrexate in south Indian Tamil patients with psoriasis","volume":"73","author":"Indhumathi","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.det.2024.02.005_bib83","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1038\/jid.2008.16","article-title":"Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis","volume":"128","author":"Warren","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"issue":"9","key":"10.1016\/j.det.2024.02.005_bib84","doi-asserted-by":"crossref","first-page":"266","DOI":"10.31083\/j.fbl2709266","article-title":"HLA-DQA1 and DQB1 Alleles are Associated with Acitretin Response in Patients with Psoriasis","volume":"27","author":"Zhou","year":"2022","journal-title":"Front Biosci (Landmark Ed)."},{"issue":"5","key":"10.1016\/j.det.2024.02.005_bib85","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/dth.12140","article-title":"HLA-G 14-bp polymorphism: a possible marker of systemic treatment response in psoriasis vulgaris? Preliminary results of a retrospective study","volume":"27","author":"Borghi","year":"2014","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.det.2024.02.005_bib86","doi-asserted-by":"crossref","first-page":"937490","DOI":"10.3389\/fphar.2022.937490","article-title":"The Inflammatory Factor SNP May Serve as a Promising Biomarker for Acitretin to Alleviate Secondary Failure of Response to TNF-a Monoclonal Antibodies in Psoriasis","volume":"13","author":"Lin","year":"2022","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.det.2024.02.005_bib87","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.jid.5700096","article-title":"Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis","volume":"126","author":"Young","year":"2006","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.02.005_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020295","article-title":"Whole Exome Sequencing in Psoriasis Patients Contributes to Studies of Acitretin Treatment Difference","volume":"18","author":"Zhou","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.det.2024.02.005_bib89","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41397-022-00291-7","article-title":"Protein network and pathway analysis in a pharmacogenetic study of cyclosporine treatment response in Greek patients with psoriasis","volume":"23","author":"Antonatos","year":"2023","journal-title":"Pharmacogenomics J"},{"issue":"11","key":"10.1016\/j.det.2024.02.005_bib90","first-page":"14","article-title":"Pharmacogenetic Study of the Impact of ABCB1 Single Nucleotide Polymorphisms on the Response to Cyclosporine in Psoriasis Patients","volume":"11","author":"Chernov","year":"2022","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.det.2024.02.005_bib91","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/tpj.2014.23","article-title":"A\u00a0pharmacogenetic study of ABCB1 polymorphisms and cyclosporine treatment response in patients with psoriasis in the Greek population","volume":"14","author":"Vasilopoulos","year":"2014","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"10.1016\/j.det.2024.02.005_bib92","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/tpj.2016.70","article-title":"IL17RA gene variants and anti-TNF response among psoriasis patients","volume":"18","author":"Batalla","year":"2018","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"10.1016\/j.det.2024.02.005_bib93","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/tpj.2016.64","article-title":"New polymorphisms associated with response to anti-TNF drugs in patients with moderate-to-severe plaque psoriasis","volume":"18","author":"Prieto-Perez","year":"2018","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"10.1016\/j.det.2024.02.005_bib94","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/tpj.2017.31","article-title":"Associations between functional polymorphisms and response to biological treatment in Danish patients with psoriasis","volume":"18","author":"Loft","year":"2018","journal-title":"Pharmacogenomics J"},{"issue":"9","key":"10.1016\/j.det.2024.02.005_bib95","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jamadermatol.2013.4632","article-title":"The role of Fcgamma receptor polymorphisms in the response to anti-tumor necrosis factor therapy in psoriasis A pharmacogenetic study","volume":"149","author":"Julia","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.02.005_bib96","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s40291-019-00409-x","article-title":"NFKBIZ and CW6 in Adalimumab Response Among Psoriasis Patients: Genetic Association and Alternative Transcript Analysis","volume":"23","author":"Coto-Segura","year":"2019","journal-title":"Mol Diagn Ther"},{"issue":"15","key":"10.1016\/j.det.2024.02.005_bib97","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2217\/pgs.15.107","article-title":"The polymorphism rs763780 in the IL-17F gene is associated with response to biological drugs in patients with psoriasis","volume":"16","author":"Prieto-Perez","year":"2015","journal-title":"Pharmacogenomics"},{"issue":"3","key":"10.1016\/j.det.2024.02.005_bib98","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40291-016-0198-z","article-title":"A\u00a0Pharmacogenetic Study of Psoriasis Risk Variants in a Greek Population and Prediction of Responses to Anti-TNF-alpha and Anti-IL-12\/23 Agents","volume":"20","author":"Masouri","year":"2016","journal-title":"Mol Diagn Ther"},{"issue":"3","key":"10.1016\/j.det.2024.02.005_bib99","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/tpj.2016.16","article-title":"FCGR3A-V158F polymorphism is a disease-specific pharmacogenetic marker for the treatment of psoriasis with Fc-containing TNFalpha inhibitors","volume":"17","author":"Mendrinou","year":"2017","journal-title":"Pharmacogenomics J"},{"issue":"5","key":"10.1016\/j.det.2024.02.005_bib100","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/bjd.15005","article-title":"Polymorphisms in CD84, IL12B and TNFAIP3 are associated with response to biologics in patients with psoriasis","volume":"176","author":"van den Reek","year":"2017","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.02.005_bib101","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/bjd.12331","article-title":"Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B\/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12\/23 blocker ustekinumab","volume":"169","author":"Talamonti","year":"2013","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.02.005_bib102","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2217\/pgs-2016-0122","article-title":"Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis","volume":"18","author":"Prieto-Perez","year":"2017","journal-title":"Pharmacogenomics"},{"issue":"1","key":"10.1016\/j.det.2024.02.005_bib103","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/jdv.15787","article-title":"Response to IL-17A inhibitors secukinumab and ixekizumab cannot be explained by genetic variation in the protein-coding and untranslated regions of the IL-17A gene: results from a multicentre study of four European psoriasis cohorts","volume":"34","author":"van Vugt","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.det.2024.02.005_bib104","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/bjd.16705","article-title":"Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study","volume":"179","author":"Costanzo","year":"2018","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.02.005_bib105","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/bjd.18013","article-title":"Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study","volume":"181","author":"Papini","year":"2019","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.det.2024.02.005_bib106","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1111\/jdv.14808","article-title":"Therapy response was not altered by HLA-Cw6 status in psoriasis patients treated with secukinumab: a retrospective case series","volume":"32","author":"Anzengruber","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.det.2024.02.005_bib107","first-page":"11","article-title":"Apremilast Pharmacogenomics in Russian Patients with Moderate-to-Severe and Severe Psoriasis","author":"Verbenko","year":"2020","journal-title":"J\u00a0Personalized Med"},{"issue":"6","key":"10.1016\/j.det.2024.02.005_bib108","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jid.2019.12.006","article-title":"The Interaction of LILRB2 with HLA-B Is Associated with Psoriasis Susceptibility","volume":"140","author":"Yanovsky","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.02.005_bib109","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3899\/jrheum.080576","article-title":"Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity","volume":"36","author":"Fisher","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"9","key":"10.1016\/j.det.2024.02.005_bib110","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/art.42154","article-title":"Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling","volume":"74","author":"Soomro","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.det.2024.02.005_bib111","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ng.693","article-title":"Genome-wide association analysis identifies three psoriasis susceptibility loci","volume":"42","author":"Stuart","year":"2010","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.det.2024.02.005_bib112","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/ng.690","article-title":"Association analyses identify six new psoriasis susceptibility loci in the Chinese population","volume":"42","author":"Sun","year":"2010","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.det.2024.02.005_bib113","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ng.2467","article-title":"Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity","volume":"44","author":"Tsoi","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.det.2024.02.005_bib114","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1038\/ncomms8001","article-title":"Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci","volume":"6","author":"Tsoi","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.det.2024.02.005_bib115","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.1038\/ncomms7916","article-title":"Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility","volume":"6","author":"Yin","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.det.2024.02.005_bib116","doi-asserted-by":"crossref","first-page":"5515868","DOI":"10.1155\/2021\/5515868","article-title":"Associations between ERAP1 Gene Polymorphisms and Psoriasis Susceptibility: A Meta-Analysis of Case-Control Studies","volume":"2021","author":"Wu","year":"2021","journal-title":"BioMed Res Int"},{"issue":"1","key":"10.1016\/j.det.2024.02.005_bib117","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000509937","article-title":"Mitochondrial Haplogroup Reveals the Genetic Basis of Diabetes Mellitus Type 2 Comorbidity in Psoriasis","volume":"30","author":"Alwehaidah","year":"2021","journal-title":"Med Princ Pract"},{"issue":"7","key":"10.1016\/j.det.2024.02.005_bib118","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2217\/pgs-2021-0019","article-title":"Exploring pharmacogenetic variants for predicting response to anti-TNF therapy in autoimmune diseases: a meta-analysis","volume":"22","author":"Antonatos","year":"2021","journal-title":"Pharmacogenomics"},{"issue":"4","key":"10.1016\/j.det.2024.02.005_bib119","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/tpj.2015.53","article-title":"Paradoxical psoriasiform reactions to anti-TNFalpha drugs are associated with genetic polymorphisms in patients with psoriasis","volume":"16","author":"Cabaleiro","year":"2016","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"10.1016\/j.det.2024.02.005_bib120","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/bjd.14461","article-title":"Common and rare CARD14 gene variants affect the antitumour necrosis factor response among patients with psoriasis","volume":"175","author":"Coto-Segura","year":"2016","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2024.02.005_bib121","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/bjd.12425","article-title":"The relationship between tumour necrosis factor (TNF)-alpha promoter and IL12B\/IL-23R genes polymorphisms and the efficacy of anti-TNF-alpha therapy in psoriasis: a case-control study","volume":"169","author":"Gallo","year":"2013","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.02.005_bib122","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00403-014-1533-z","article-title":"The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patients","volume":"307","author":"Gonzalez-Lara","year":"2015","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"10.1016\/j.det.2024.02.005_bib123","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar2419","article-title":"Molecular discrimination of responders and nonresponders to anti-TNF alpha therapy in rheumatoid arthritis by etanercept","volume":"10","author":"Koczan","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.det.2024.02.005_bib124","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/ard.2007.074104","article-title":"A\u00a0single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis","volume":"67","author":"Miceli-Richard","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.det.2024.02.005_bib125","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/ced.12323","article-title":"Genetic markers of treatment response to tumour necrosis factor-alpha inhibitors in the treatment of psoriasis","volume":"39","author":"Ryan","year":"2014","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.02.005_bib126","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/rheumatology\/kel175","article-title":"The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients","volume":"46","author":"Seitz","year":"2007","journal-title":"Rheumatology"},{"issue":"3 Pt 1","key":"10.1016\/j.det.2024.02.005_bib127","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/jid.2011.376","article-title":"TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis","volume":"132","author":"Tejasvi","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.02.005_bib128","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF03256427","article-title":"Pharmacogenetic analysis of TNF, TNFRSF1A, and TNFRSF1B gene polymorphisms and prediction of response to anti-TNF therapy in psoriasis patients in the Greek population","volume":"16","author":"Vasilopoulos","year":"2012","journal-title":"Mol Diagn Ther"},{"issue":"5","key":"10.1016\/j.det.2024.02.005_bib129","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/bjd.13056","article-title":"Human leucocyte antigen-Cw6 as a predictor for clinical response to ustekinumab, an interleukin-12\/23 blocker, in Chinese patients with psoriasis: a retrospective analysis","volume":"171","author":"Chiu","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2024.02.005_bib130","doi-asserted-by":"crossref","first-page":"815121","DOI":"10.3389\/fimmu.2021.815121","article-title":"Genome-Wide Association Study of Ustekinumab Response in Psoriasis","volume":"12","author":"Connell","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.det.2024.02.005_bib131","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000441719","article-title":"IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis","volume":"232","author":"Galluzzo","year":"2016","journal-title":"Dermatology"},{"issue":"12","key":"10.1016\/j.det.2024.02.005_bib132","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.jid.2016.06.631","article-title":"HLA-C\u221706:02 Allele and Response to IL-12\/23 Inhibition: Results from the Ustekinumab Phase 3 Psoriasis Program","volume":"136","author":"Li","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.02.005_bib133","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jaad.2015.08.055","article-title":"HLA-C\u221706 and response to ustekinumab in Caucasian patients with psoriasis: Outcome and long-term follow-up","volume":"74","author":"Talamonti","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.02.005_bib134","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/bjd.15387","article-title":"Role of the HLA-C\u221706 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patients","volume":"177","author":"Talamonti","year":"2017","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.02.005_bib135","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jamadermatol.2019.0098","article-title":"Association of HLA-C\u221706:02 Status With Differential Response to Ustekinumab in Patients With Psoriasis: A Systematic Review and Meta-analysis","volume":"155","author":"van Vugt","year":"2019","journal-title":"JAMA Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863524000172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863524000172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T21:39:36Z","timestamp":1716500376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863524000172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":135,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0733863524000172"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2024.02.005","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Genetics on Psoriasis Susceptibility, Comorbidities, and Treatment Response","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2024.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}